JP2006502702A5 - - Google Patents

Info

Publication number

JP2006502702A5

JP2006502702A5 JP2004501455A JP2004501455A JP2006502702A5 JP 2006502702 A5 JP2006502702 A5 JP 2006502702A5 JP 2004501455 A JP2004501455 A JP 2004501455A JP 2004501455 A JP2004501455 A JP 2004501455A JP 2006502702 A5 JP2006502702 A5 JP 2006502702A5

Authority

JP

Japan

Prior art keywords

seq

polypeptide

nucleic acid

amino acid

acid molecule

Prior art date

2003-04-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 claims 24
• 102000004196 processed proteins & peptides Human genes 0.000 claims 24
• 108090000765 processed proteins & peptides Proteins 0.000 claims 24
• 150000007523 nucleic acids Chemical class 0.000 claims 15
• 108020004707 nucleic acids Proteins 0.000 claims 13
• 102000039446 nucleic acids Human genes 0.000 claims 13
• 125000003275 alpha amino acid group Chemical group 0.000 claims 9
• 201000010099 disease Diseases 0.000 claims 7
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
• 210000004027 cell Anatomy 0.000 claims 6
• 239000012634 fragment Substances 0.000 claims 6
• 230000000694 effects Effects 0.000 claims 5
• 239000003446 ligand Substances 0.000 claims 5
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
• 150000001875 compounds Chemical class 0.000 claims 4
• 238000003745 diagnosis Methods 0.000 claims 3
• 230000014509 gene expression Effects 0.000 claims 3
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
• 150000001413 amino acids Chemical class 0.000 claims 2
• 230000000890 antigenic effect Effects 0.000 claims 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 2
• 208000023275 Autoimmune disease Diseases 0.000 claims 1
• 208000024172 Cardiovascular disease Diseases 0.000 claims 1
• 208000012239 Developmental disease Diseases 0.000 claims 1
• 108060003951 Immunoglobulin Proteins 0.000 claims 1
• 208000026350 Inborn Genetic disease Diseases 0.000 claims 1
• 208000012902 Nervous system disease Diseases 0.000 claims 1
• 208000025966 Neurological disease Diseases 0.000 claims 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 claims 1
• 125000000539 amino acid group Chemical group 0.000 claims 1
• 230000003321 amplification Effects 0.000 claims 1
• 230000001363 autoimmune Effects 0.000 claims 1
• 230000007423 decrease Effects 0.000 claims 1
• 108020001507 fusion proteins Proteins 0.000 claims 1
• 102000037865 fusion proteins Human genes 0.000 claims 1
• 208000016361 genetic disease Diseases 0.000 claims 1
• 102000018358 immunoglobulin Human genes 0.000 claims 1
• 208000015181 infectious disease Diseases 0.000 claims 1
• 208000027866 inflammatory disease Diseases 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 208000030159 metabolic disease Diseases 0.000 claims 1
• 238000000034 method Methods 0.000 claims 1
• 239000000203 mixture Substances 0.000 claims 1
• 238000003199 nucleic acid amplification method Methods 0.000 claims 1
• 239000002853 nucleic acid probe Substances 0.000 claims 1
• 230000001575 pathological effect Effects 0.000 claims 1
• 230000002062 proliferating effect Effects 0.000 claims 1
• 208000020016 psychiatric disease Diseases 0.000 claims 1
• 239000000523 sample Substances 0.000 claims 1
• 229940126585 therapeutic drug Drugs 0.000 claims 1
• 229960005486 vaccine Drugs 0.000 claims 1